Canada · Funded startup

Who invested in Myomar Molecular

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$1.4Mraised across 2 rounds since 2026, from 2 sources

$37KGrant$1.4MDebt
Latest round
Debt, $1.4MMay 2026
Step-upi
37.8×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027
$37KGrant$1.4MDebt
First round
Grant, $37K
Mar 2026
Biggest round
$1.4M
Debt · May 2026
Between rounds
2 months
from the last two

The rounds

  1. May 2026
  2. Mar 2026

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Myomar Molecular as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

MaRS Discovery DistrictInvestment firmPer its own site
Women's Equity LabVC firmPer its own site

Quick answers about Myomar Molecular

Who invested in Myomar Molecular?

Myomar Molecular's investors include BDC Capital, Atlantic Canada Opportunities Agency and Ontario Centres of Excellence.

How much has Myomar Molecular raised?

Myomar Molecular has raised $1.4M across 2 rounds since 2026.

When did Myomar Molecular last raise?

Myomar Molecular's most recent round was a Debt of $1.4M in May 2026.

What was Myomar Molecular's biggest round?

Its most recent round, $1.4M in May 2026, is also its largest on record.

Who backed Myomar Molecular first?

Myomar Molecular's first round on record, in Mar 2026, was backed by BDC Capital and Atlantic Canada Opportunities Agency.

What stage is Myomar Molecular at?

Myomar Molecular's latest named round is a Debt, in May 2026.

Where is Myomar Molecular based?

Myomar Molecular is based in Canada.

Companies like Myomar Molecular

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.